Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Swertia japonica whole flowering, commonly known as senburi, is a botanical extract derived from the whole flowering plant of *Swertia japonica*. It is traditionally used in Japanese medicine to treat various gastrointestinal conditions, including nausea, gastroparesis, and gastric atony. The extract contains several bitter-tasting secoiridoid glycosides, such as swertiamarin, sweroside, amarogentin, amaroswerin, and gentiopicroside. Its therapeutic effect is primarily attributed to the stimulation of gastric emptying and gastrointestinal motility through the inhibition of dopamine D2 receptors. While it is not an FDA-approved pharmaceutical drug, it is marketed in over-the-counter products like Molyhen and is also utilized in cosmetic formulations for its potential biological activities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Swertia japonica whole flowering.